Geftinat 250 mg tablet
66.86$
34.00$
Geftinat 250 mg tablets are a targeted therapy designed to treat non-small cell lung cancer (NSCLC) that has metastasized in patients with specific mutations in the EGFR gene who have not undergone prior treatment for their cancer. This medication works by inhibiting the activity of the epidermal growth factor receptor, thereby slowing tumor growth and progression. It is important to note that Geftinat is not approved for use in pediatric patients due to insufficient evidence regarding its safety and efficacy in children and adolescents. While Geftinat can be an effective option for eligible adults, potential side effects may include skin rashes, diarrhea, and liver function abnormalities, necessitating regular monitoring by healthcare professionals. Patients should be aware of these possible reactions and discuss any concerns with their physician before starting treatment. This medication represents a significant advancement in targeted cancer therapy, offering hope to individuals battling advanced NSCLC. As with all cancer therapies, adherence to prescribed regimens and follow-up appointments is crucial for optimal outcomes.
الكمية
Active Pharmaceutical Ingredient
Uses
• Geftinat 250 mg tablet is primarily used in the treatment of non-small cell lung cancer. This type of lung cancer affects a large portion of lung tissue and can be challenging to manage. By targeting specific pathways involved in cancer cell growth, Geftinat helps to slow down disease progression. Patients receiving this medication often experience improved outcomes in their treatment journey.
• In addition to its role in treating non-small cell lung cancer, Geftinat 250 mg tablet is utilized for patients with certain types of lung tumors that are sensitive to its active ingredients. This targeted therapy can lead to a reduction in tumor size and improved respiratory function. Many healthcare providers recommend Geftinat for patients who have not responded adequately to other treatment options. Its effectiveness in specific genetic contexts further enhances its clinical utility.
• Geftinat 250 mg tablet may also be prescribed for patients with metastatic non-small cell lung cancer, where the cancer has spread beyond the lungs. This medication can help manage symptoms and improve quality of life for those affected. By focusing on the molecular characteristics of the cancer, Geftinat offers a tailored approach to treatment. This personalized strategy is particularly beneficial for patients with advanced stages of the disease.
• Healthcare professionals often consider Geftinat 250 mg tablet as part of a comprehensive treatment plan for non-small cell lung cancer. It is frequently combined with other therapies to enhance overall efficacy. The use of Geftinat can lead to better management of the disease and may prolong survival in select patient populations. Its role in modern oncology underscores the importance of targeted therapies in cancer treatment.
Benefits
Gefitinib Tablet 250 mg inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Geftinat Tablet may help to slow the progression of cancer.
Geftinat 250 mg may help reduce the severity of cancer-related symptoms, such as pain and fatigue, which can improve a patient's overall quality of life.
Gefitinib Tablet 250 mg may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.
Side Effects
As with all medicines, Geftinat 250 mg Strip may cause some side effects. If you experience any of these side effects, you should contact your doctor or health care professional as soon as possible. Your doctor may be able to suggest ways in which these side effects can be managed or the severity of them reduced.
Most Common Side Effects
• Tremor
• Hypertension
• Headache
• Increased Potassium levels in the blood
• Hypertension
• Gastrointestinal problems
• Abnormal Growth of Hair
Common Side Effects
• Liver Damage
• Seizures
• Infection
• Kidney Damage
• Memory Problems
• Vision Problems
• Sleeplessness
How To Use
It is recommended to consume Geftinat 250 mg Strip with or without food. Be sure to swallow the tablet whole with a complete glass of water. Avoid crushing, chewing, or opening the tablet. In case you forget to take a dose, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose and adhere to your regular dosing schedule. Remember not to take two doses simultaneously to compensate for a missed dose.
Safety Advice
• Alcohol: The use of alcohol is generally not recommended while taking Anti-cancer Drug Geftinat as it may increase the risk of liver damage. It is advisable to either abstain from alcohol or limit your alcohol intake while taking any medication.
• Kidney: Geftinat 250 mg tablet is considered safe for patients with mild to moderate kidney disease and no dose adjustment of Geftinat 250 mg is required. However, people with severe kidney disease are advised not to take Geftinat Tablet Tablet. To ensure the safety and effectiveness of your treatment, it is important to have an open discussion with your doctor about all your medical conditions and medications.
• Breastfeeding: It is not advisable to breast-feed while taking Geftinat Tablet as this may cause harm to the baby. Geftinat 250 mg tablet can pass into breast milk and cause adverse effects. If you are currently breastfeeding and using Gefitinib Tablet 250 mg, it is important to discuss with your doctor the potential risks and benefits of continuing to breastfeed. Your doctor will help you make the decision that is best for you and your baby.
• Liver: Geftinat 250 mg tablet is considered safe for patients with mild to moderate liver disease, and there is no need to adjust the dose of Gefitinib Tablet 250 mg. However, people with severe liver disease should not use Anti-cancer Drug Geftinat. It is important to have an open discussion with your doctor about your medical conditions and medications to ensure that the treatment plan is appropriate for you.
• Pregnancy: Geftinat 250 mg tablet may be unsafe during pregnancy as animal studies suggest that it may harm the developing fetus. However, if you are pregnant or planning to get pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Geftinat 250 mg Strip while pregnant. Your doctor will be able to help you make the decision that is best for you and for the health of your baby.
• Driving: Geftinat 250 mg tablet may cause dizziness, drowsiness, and problems with concentration and coordination, which may impair your ability to drive a vehicle safely. It is important that you follow your doctor's instructions and take the necessary measures, such as avoiding driving or operating heavy machinery, if you experience any of these side effects caused by Gefitinib Tablet 250 mg.